A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial-Reference-Cited by-同舟云学术

A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial

Published:2022-04 Issue:4 Volume:7 Page:307-317
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Solomon Sunil S,Wagner-Cardoso Sandra,Smeaton Laura,Sowah Leonard A,Wimbish Chanelle,Robbins Gregory,Brates Irena,Scello Christine,Son Annie,Avihingsanon Anchalee,Linas Benjamin,Anthony Donald,Nunes Estevão Portela,Kliemann Dimas A,Supparatpinyo Khuanchai,Kityo Cissy,Tebas Pablo,Bennet Jaclyn Ann,Santana-Bagur Jorge,Benson Constance A,Van Schalkwyk Marije,Cheinquer Nelson,Naggie Susanna,Wyles David,Sulkowski Mark

Funder

National Institute of Allergy and Infectious Diseases

Gilead Sciences Inc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Global elimination of chronic hepatitis;Thomas;N Engl J Med,2019

2. Progress towards hepatitis C virus elimination in high-income countries: an updated analysis;Gamkrelidze;Liver Int,2021

3. A guide to the economics of hepatitis C virus cure in 2017;Linas;Infect Dis Clin North Am,2018

4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

5. Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection;Chaillon;PLoS One,2019

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. Impact of a Pharmacist-Led HCV Treatment Program at a Federally Qualified Health Center;Pharmacy;2024-07-24

3. Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?;World Journal of Hepatology;2024-05-27

4. United States Provider Experiences with Telemedicine for Hepatitis C Treatment: A Nationwide Survey;2024-05-13

5. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial);Scientific Reports;2024-05-03